Direct-to-consumer virtual healthcare company Ro has acquired Dadi, a male fertility and sperm testing startup.
The move comes less than a year after Ro boasted another company focused on reproductive health, Modern Fertility.
As part of the deal, the virtual healthcare company will discontinue the Dadi name and launch the Ro Sperm Kit, which allows users to collect samples at home for analysis and storage. The kit will be available through Modern Fertility and Roman, Ro’s men’s health brand.
“Fertility support has long been complex and reactive, making it difficult for people to take an active role in their health journey. Dadi has completely reinvented the experience of testing, analyzing and preserving sperm, making these services more accessible, more convenient and affordable,” Ro co-founder and CEO Zachariah Reitano said in a statement.
“Now, Ro will bring this patient-centered experience to more people through Ro Sperm Kit and in the future, create the most comprehensive direct-to-patient fertility products and services in the country for both individuals and couples.”
WHY IT MATTER
According to the CDC, about 9% of men ages 25 to 44 in the US reported that they or their partner had seen a doctor for advice, testing, or treatment for infertility. In about 35% of couples struggling with infertility, a male cause is identified in addition to a female factor, and in about 8% a male concern is the only identifiable cause.
There are plenty of other players in the tech-enabled fertility space, though many focus on women. Last month, hybrid reproductive care company Kindbody announced plans to acquire the Vios Fertility Institute, a network of clinics. The company also recently launched a range of male and female hormone tests for the home.
Proov, which also offers home testing for men and women, raised $9.7 million in Series A financing in December. Another company that focuses specifically on male fertility is Legacy, which offers semen analysis and storage.
THE BIGGER TREND
Outside of last year’s acquisition of Modern Fertility, virtual healthcare company DTC has been rapidly closing other deals to expand its offerings.
In June bought it home diagnostics company Kit, not long after the Modern Fertility deal. In late 2020, it picked up Workpath, which provides an API system for home care and lab treatment. TechCrunch reported that Ro was in talks to acquire Dadi in November.
Ro recently scored $150 million in funding, building on a massive $500 million investment from last year.